SCREENINGVERFAHREN ZUM IDENTIFIZIEREN PROTEKTIVER SUBSTANZEN FÜR DIE BEHANDLUNG NEURODEGENERATIVER UND/ODER ISCHÄMISCHER ERKRANKUNGEN

摘要

The present invention relates to a screening method for the identification of protective substances which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells, as well as to recombinant constructs, host cells and transgenic animals for the implementation of this method. In addition, the present invention relates to a diagnostic method for the differential diagnosis of neurodegenerative and/or ischaemic diseases in mammals and the use of haemoglobin, a globin or a mutein or fusion protein thereof or a corresponding nucleic acid for the treatment of neurodegenerative and/or ischaemic diseases in mammals. The invention furthermore relates to constructs for gene therapy of such diseases.